Article 6M63Q Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023

Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron–Associated Hospitalization in Children and Adolescents — United States, 2021–2023

by
from Morbidity and Mortality Weekly Report (MMWR) on (#6M63Q)
This report describes the duration of protection provided by the original monovalent COVID-19 vaccines.
External Content
Source RSS or Atom Feed
Feed Location http://www2c.cdc.gov/podcasts/createrss.asp?t=r&c=5
Feed Title Morbidity and Mortality Weekly Report (MMWR)
Feed Link https://www.cdc.gov/mmwr/index.html
Reply 0 comments